Exane Derivatives’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Exane Derivatives’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$158	Hold	14	–	–	﹤0.01%	693
2022 Q1	$227	Hold	14	–	–	﹤0.01%	951
2021 Q4	$663	Hold	14	–	–	﹤0.01%	743
2021 Q3	$1.01K	Sell	14 -3,750	-100%	-$271K	﹤0.01%	862
2021 Q2	$287K	Hold	3,764	–	–	0.07%	298
2021 Q1	$182K	Buy	+3,764	New	+$204K	0.05%	315

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exane Derivatives's NBP Position: Q2 2022 in Review

Exane Derivatives held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2022 at 14 shares worth $158. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Exane Derivatives first reported a position in NBP in Q1 2021 and has held it in 6 quarters since. The position peaked at $287K in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

Exane Derivatives held 14 shares of NovaBridge Biosciences American Depositary Shares worth $158 as of Q2 2022.
Exane Derivatives left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2022.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #693 holding.
Exane Derivatives first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and has held it in 6 quarters since.
Exane Derivatives's NovaBridge Biosciences American Depositary Shares position peaked at $287K in Q2 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.